##
##
##
||`Page`|
|---|---|
|`MessagefromtheChairmanandtheChiefExecutive`||
|`ReportoftheTrustees`|`5to20`|
|`ReportoftheIndependentAuditors`|`21to24`|
|`StatementofFinancialActivities`|`25`|
|`BalanceSheet`|`26`|
|`CashFlowStatement`|`28`|
|`NotestotheCashFlowStatement`|`29`|
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
|`Risk`|`Actions`|
|---|---|
|
`Insufficientincometooperatesustainably,leadingto| WiththewithpressuresontheUKeconomy`||
|`asustained reductioninfreereserves`|`causinghighinflationandcostoflivingconcerns`|
||`forindividuals,thefundraisingenvironmentis`|
||`anticipatedtobeextremelydifficultforallcharities.`|
||`TheCharityhasestablishedreserveswhichwill`|
||`supportitintheimmediatefuture,butweareaware`|
||`thatgeneratingincomewillbechallengingandthat`|
||`therearea numberofareaswhereweneedtoinvest`|
||`topositiontheCharitytomeetthenextphaseof`
|
||`itsgrowth.Asa resultweareforecastingtoneedto`
|
||`drawsignificantlyonthesereservesinthenextone`
|
||`totwoyears.`
|
||`Wearelookingtoincreaseanddiversifyour`
|
||`incomestreamsbyenhancingandinvestinginour`
|
||`fundraisingteamandactivities.Costreduction`
|
||`measureshavealsobeenputinplacethroughFY23`
|
||`whichwillbesustainedintoFY24andbeyond.`
|
##
|
`Risk`|
`Actions`|
|---|---|
|
`Maintainingstrongandeffectiverelationshipswith`|
`TheCharityhasa numberofkeyrelationships`|
|`keystakeholderssuchasresearchpartnersandmajor`|`withkeypartnersanddonorswhichareessential`|
|`donors`|`toeitherfundouractivitiesatthecurrentlevelor`|
||`todelivercollaborativeprojectssuchasprostate`|
||`cancerdetection.Weareinvestinginimprovingand`|
||`enhancingourcommunicationsandrelationships`|
||`withtheseorganisationsandindividualsto`|
||`strengthentheselinks.`|
|
`Insufficientseniororkeystaffduetolossofor`|
`Recruitmentandretentionisa majorissueforall`|
|`inabilitytorecruitorretainkeypersonnel.`|`organisationsatthemoment.Thecostofliving`|
||`crisisandshortageofavailableskilledpersonnelis`|
||`asignificantriskbothforcontrollingcostsandfor`|
||`maintainingtheworkforceneededtodeliver.`|
||`TheCharityalwaysseekstospendasmuchas`|
||`possibleofourfundsonourcharitablegoals,and`|
||`thereforedoesnothavea largemanagementteam.`|
||`Consequently,werelyona smallnumberofkey`|
||`people,mostnotablytheCEO,todrivetheCharity`|
||`forwardsandtomanageday-to-dayactivities.`|
||`Overthepastyearwehavetakenseveral`|
||`positivestepstoaddressthis.Mostnotablythe`|
||`implementationofa SeniorLeadershipTeammade`|
||`upofsevenkeystaffmembers,plustheCEO.This`
|
||`stepisa substantialoneasitmovestheCharityaway`
|
||`fromhavingheavyorsolerelianceononeortwo`
|
||`individualsforthedaytodayrunningofoperations.`
|
||`Wearelookingatsuccessionplanningand`
|
||`implementinga developmentpipelinetosafeguard`
|
||`againsttheriskoflosingkeypeople.Given`
|
||`thespecialisednatureandscaleoftheCharity`
|
||`thisrepresentsa particularchallengeinsome`
|
||`departments,whichwearebeginningtoactively`
|
||`engageintodeterminethebestwayforwards.`
|
|
`Insufficientvolunteerstosupportourservice`|
`Likemostcharities,werelyheavilyona volunteers`
|
|
`delivery`|
`inmanyareasofouractivities,fromfundraising`
|
||
`tosupportindeliveringourcharitableactivities.`
|
||
`Thereiscurrentlya nationalshortageofvolunteers`
|
||
`tofosterdogswhichisbeginningtoimpactonthe`
|
||
`numberofdogswecantrainanddeploy.`
|
||
`WeareexploringothermodelsforourMAAD`
|
||
`workwhichdonotrequiretheuseofanyfosterers,`
|
||
`withoutimpactingonourcoreprinciplethatallour`
|
||
`dogsshouldliveinhomes,notkennels.Greateruse`
|
||
`ofclients’owndogsmighthelpusinthisregard.We`
|
||
`arealsoexploringtheestablishmentofregionalhubs`
|
||
`whichcouldallowus totargetnewgeographicareas`
|
||
`forrecruitingfosterers.`
|
##
|
`Risk`|
`Actions`|
|---|---|
|
`InvestmentinFundraisingteamtoreturnthecharity`|
`Withthecharityintentiallyrecordinga deficitfor`|
|`toa breakevenposition`|`the2022/23year(andwitha similarprojectionfor`|
||`2023/24),a deliberateandcoordinatedendeavor`|
||`hasbeenundertakentoincreasetheproportion`|
||`ofexpenditurespentonfundraisingactivitiesand`|
||`relatedinitiatives.`|
||`Withthisinvestment,itisimportantthatthe`|
||`additionalexpenditureworkstoyieldanincreasein`|
||`ourunderlyingincome,andreturnsthecharitytoa `|
||`breakevenposition.`|
||`Thissupportstheoverarchingobjectivetoreturnthe`|
||`charitytoa stateofequilibrium,whereunderlying`|
||`incomematchesunderlyingexpenditure.`|
|
`ReductioninBioResearchfundingandpressureson`|
`DuringtheCOVID-19pandemic,ourBioresearch`|
|
`ourNHSpartners`|`teamwasthefocusofthecharityandreceiveda high`|
||`numberofdonationssupportingresearchintohow`|
||
`caninedetectioncouldsupporttheUKduringthe`
|
||
`pandemic.`
|
||
`Followingthisperiod,therehasbeena significant`
|
||
`reductioninthefundingavailableforBioresearch`
|
||
`projects.Thisissupplementedbyincreasing`
|
||
`pressuresontheNHS,narrowingtheabilityofNHS`
|
||
`Truststocollaboratewithusonresearchworks`
|
||
`astheirresourcesaredivertedtowardsfrontline`
|
||
`support.`
|
||
`Asa resultwehavereducedthebalanceofresources`
|
||
`allocatedtoourBioresearchdepartment.Weexpect`
|
||
`thecurrent,reducedsizeoftheteamtocontinue`
|
||
`untilfundingforfutureprojectsissecured.A risk`
|
||
`existsthatiftheteamsizeneedstobereduced`
|
||
`furtherthatthecumulativeknowledgeandexpertise`
|
||
`inBioresearch,whichhasbeenbuiltupovermany`
|
||
`years,islostintheshortterm.Thislossofknowledge`
|
||
`andteamexperiencewouldtake18monthsormore`
|
||
`toreplace.`
|
##
|`Risk`|`Actions`|
|---|---|
|
`CompliancewithDBSandSafeguardingstandards`|
`ItisvitalthatMDDmaintainsitshighstandardswith`|
||`regardstosafeguardingthevulnerablepeoplewe`|
||`support.`|
||`AssuchanongoingreviewandrenewalofDisclosure`|
||`andBarringService(DBS)policies,proceduresand`|
||`checkingforallstaffandvolunteerswhoencounter`|
||`vulnerableindividualsisinplace.`|
||`Similarlywereviewalloursafeguardingtraining:all`|
||`staffdeliveringourworkwhichMDDhasidentified`|
||`asmeaningtheymayhavecontactwithvulnerable`|
||`adultsorchildrenmustachieveLevel2 safeguarding`|
||`trainingstandards(withanyothermemberofstaff`|
||`maintainingLevel1).`|
||`Aleadershipstructureisinplacetooverseethe`|
||`maintenanceofsafeguardingstandards,which`|
||`includesa Trusteesafeguardinglead,aswellasan`|
||`employeeleadwhositsontheSeniorLeadership`|
||`Team.`|
|
`Dataqualityimprovement`|
`Toenhanceourfundraisingcapabilities,we`|
||`acknowledgetheimperativeofmaintaininga `|
||`robustlevelofdataquality,specificallycuratedfor`|
||`fundraisingpurposes,allthewhileupholdingGDPR`|
||`complianceinthehandlingofthisinformation.`|
||`Ourcommitmenttostaffproficiencyindatabase`
|
||`systemsremains,andisupheldthroughongoing`
|
||`trainingofrelevantstaff.Additionally,wehave`
|
||`undertakenanevaluationofhistoricaldataviaa `
|
||`datacleansingassessment.Whileweadheretoall`
|
||`GDPRprotocols,furthermeasurescanbetakento`
|
||`consistentlyelevatethequalityofourfundraising`
|
||`data.This,inturn,willenableourdatatodrive`
|
||`decisionmaking.`
|
|
`Cybersecurityandlossofinformationrisk`|
`Astechnologycontinuestoevolve,thedemandfor`
|
||
`anacceleratedrateofprogresstoremaininstep,as`
|
||
`wellasthepotentialriskslinkedtonotembracing`
|
||
`thischange,becomemorepronounced.Cyber`
|
||
`securityattacksarebecomingmoreregularacross`
|
||
`allorganisationsandcanhaveanenormousadverse`
|
||
`impact.`
|
||
`MDDhasrecentlyinvestedinourITinfrastructure`
|
||
`tobringusinlinewithsimilarlysizedorganisations,`
|
||
`enablingourstafftoworkefficientlyandeffectively,`
|
||
`whilstalsofutureproofingtheCharityforexpected`
|
||
`technologydevelopments.`
|
||
`Inordertocontinuallymovewiththese`
|
||
`developmentsweemploya dedicatedITexpert`
|
||
`withinthecharity,andhavemovedmanyofour`
|
||
`supportsystemstoa dedicatedITsupportpartner.`
|
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
# 19 October 2023
##
||||||`2023`|`2022`|
|---|---|---|---|---|---|---|
|||`Unrestricted`||`Restricted`|`Totalfunds`|`Totalfunds`|
|||`fund`||`funds`|||
||`Notes`|
`£`||`£`|`£`|`£`|
|`INCOMEANDENDOWMENTSFROM`|||||||
|`Donationsandlegacies`|`3`|`1,137,365`||`688,492`|`1,825,857`|`2,474,281`|
|`Othertradingactivities`|`4`|`47,985`||`-`|`47,985`|`63,663`|
|`Investmentincome`|`5`|`15,193`||`-`|`15,193`|`672`|
|`Governmentgrants`|`5`||`-`|`-`|`-`|`13,439`|
|||
`1,200,543`|
|
`688,492`|
`1,889,035`|
`2,552,055`|
|`Total`|||||||
|`EXPENDITUREON`|||||||
|`Raisingfunds`|`6`|`137,920`||`76,429`|`214,349`|`163,202`|
|`Charitableactivities`|`7`||||||
|`Dogtraining`||`354,490`||`174,141`|`528,631`|`420,812`|
|`Assistancedogplacementandaftercare`||`571,073`||`318,383`|`889,456`|`810,751`|
|`BioDetectionresearchprojects`||`474,376`||`27,093`|`501,469`|`535,131`|
|`Educationandawareness`||`136,264`||`0`|`136,264`|`158,483`|
|`Volunteerliaison`||
`121,965`|
|
`102,857`|
`224,822`|
`195,617`|
|`Total`||`1,796,088`||`698,903`|`2,494,991`|`2,283,996`|
|`NETINCOME`||
`(595,545)`|
|
`(10,411)`|
`(605,956)`|
`268,059`|
|`Transfersbetweenfunds`|`18`|
`-`||
`-`|
`-`|
`-`|
|`Netmovementinfunds`||`(595,545)`||`(10,411)`|`(605,956)`|`268,059`|
|`RECONCILIATIONOFFUNDS`|||||||
|`Totalfundsbroughtforward`||`4,218,207`||`594,746`|`4,812,953`|`4,544,894`|
|`TOTALFUNDSCARRIEDFORWARD`||
`3,622,663`||
`584,333`
|
`4,206,996`
|
`4,812,953`
|
##
|||||||`2023`|`2022`|
|---|---|---|---|---|---|---|---|
|||`Unrestricted`|`Restricted`|||`Totalfunds`|`Totalfunds`|
|||`fund`|`funds`|||||
||`Notes`|
`£`|`£`|||`£`|`£`|
|`FIXEDASSETS`||||||||
|`Tangibleassets`|`12`|`1,738,013`||`-`||`1,738,013`|`1,807,911`|
|`Investments`|`13`|`4`||`-`||`4`|`5`|
|||
`1,738,017`|
|
|
`-`|
`1,738,017`|
`1,807,916`|
|`CURRENTASSETS`||||||||
|`Stocks`|`14`|`5,992`||`-`||`5,992`|`10,648`|
|`Debtors`|`15`|`396,625`||`-`||`396,625`|`728,346`|
|`Cashatbankandinhand`||`1,643,571`|`584,333`|||`2,227,904`|`2,512,181`|
|||
`2,163,438`|
`584,333`|
||
`2,630,521`|
`3,251,175`|
|`CREDITORS`||||||||
|`Amountsfallingduewithinoneyear`|`16`|`(161,541)`||`-`||`(161,451)`|`(246,138)`|
|`NETCURRENTASSETS`||
`1,884,647`|
`584,333`|
||
`2,468,980`|
`3,005,037`|
|`TOTALASSETSLESSCURRENT`||
`3,622,663`|
`584,333`|
|
|
`4,206,996`|
`4,812,952`|
|`LIABILITIES`|||
|
|
|
|
|
|`NETASSETS`||
`3,622,663`|
`584,333`|
||
`4,206,996`|
`4,812,952`|
|`FUNDS`||||||||
|`Unrestrictedfunds`|`18`|||||`3,622,663`|`4,218,207`|
|`Restrictedfunds`|`18`|||||`§84,333`|`594,746`|
|`TOTALFUNDS`||||||
`4,206,996`|
`4,812,952`|
##
|||||||`2023`|`2022`|
|---|---|---|---|---|---|---|---|
|||`Unrestricted`|`Restricted`|||`Totalfunds`|`Totalfunds`|
|||`fund`|`funds`|||||
||`Notes`|
`£`|`£`|||`£`|`£`|
|`FIXEDASSETS`||||||||
|`Tangibleassets`|`12`|`1,738,013`||`-`||`1,738,013`|`1,807,911`|
|`Investments`|`13`|`5`||`-`||`5`|`5`|
|||
`1,738,018`|
|
|
`-`|
`1,738,018`|
`1,807,916`|
|`CURRENTASSETS`||||||||
|`Stocks`|`14`|`5,992`||`-`||`5,992`|`10,648`|
|`Debtors`|`15`|`396,625`||`-`||`396,625`|`728,346`|
|`Cashatbankandinhand`||`1,643,571`|`584,333`|||`2,227,904`|`2,512,181`|
|||
`2,046,188`|
`584,333`|
|
|
`2,630,521`|
`3,251,175`|
|`CREDITORS`||||||||
|`Amountsfallingduewithinoneyear`|`16`|`(161,541)`||`-`||`(161,541)`|`(246,138)`|
|`NETCURRENTASSETS`||
`1,884,647`|
`584,333`|
|
|
`2,468,980`|
`3,005,036`|
|`TOTALASSETSLESSCURRENT`||
`3,622,664`|
`584,333`|
|
|
`4,206,997`|
`4,812,952`|
|`LIABILITIES`|||
|
|
|
|
|
|`NETASSETS`||
`3,622,664`|
`584,333`|
|
|
`4,260,997`|
`4,812,952`|
|`FUNDS`||||||||
|`Unrestrictedfunds`|`18`|||||`3,622,664`|`4,218,207`|
|`Restrictedfunds`|`18`|||||`584,333`|`504,746`|
|`TOTALFUNDS`||||||
`4,206,997`|
`4,812,952`|
||||`2023`|`2022`|
|---|---|---|---|---|
||`Notes`||||
|`Netcash(usedin)providedbyoperating`
`activities`|`A`||`(246,340)`|`(35,371)`|
|`Cashflowsfrominvestingactivities:`
`Purchaseoftangiblefixedassets`|||`(54,631)`|`(127,235)`|
|`Saleoftangiblefixedassets`|||`1,500`||
|`Investmentincome`|||`15,193`|`672`|
|`Netcash(usedin)investingactivities`||`"`|`(37,937)`|`(126,563)`|
|`Changeincashandcashequivalentsinthe`
`reportingperiod`|||`(284,277)`|`(161,934)`|
|`Cashandcashequivalentsatthebeginning`
`ofthereportingperiod`|||`2,512,181`|`2,674,115`|
|`Cashandcashequivalentsattheendofthe`
`reportingperiod`|||`2,227,904`|`2,012,181`|
##
||`2023`|`2022`|
|---|---|---|
||`£`|`£`|
|`Netincomeforthereportingperiod(asperthestatementof`|||
|`financialactivities)`|`(605,956)`|`268,059`|
|`Adjustmentsfor:`|||
|`Depreciationcharges`|`122,700`|`109,657`|
|`Lossonsaleoffixedassets`|`330`|`-`|
|`Interestreceived`|`(15,193)`|`(672)`|
|`(Increase)/ Decreaseinstocks`|`4,656`|`(3,341)`|
|`(Increase)/ Decreaseindebtors`|`331,721`|`(511,026)`|
|`Increase/ (Decrease)increditors`|
`(84,598)`|
`101,952`|
|`Netcash(usedin)providedbyoperatingactivities`|`(246,340)`|`(35,371)`|
##
|
`Asat`|
`Cashflow`|`Asat`|
|---|---|---|
|
`1/4/2022`||`31/3/2023`|
|`2,512,181`|`(284,277)`|`2,227,904`|
|
`2,512,181`
|
`(284,277)`
|
`2,227,904`
|
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
|`Freeholdproperty`|`-2%oncost`|
|---|---|
|`Fixturesandfittings`|`-Straightlineover3 years`|
|`Motorvehicles`|`-Straightlineover3 years`|
##
##
##
##
##
##
||`2023`|`2022`|
|---|---|---|
||`£`|`£`|
|`Donationsandgrants`|`1,567,452`|`1,750,483`|
|`Legacies`|`258,405`
|`723,798`
|
||`1,825,857`
|`2,474,281`
|
|`4.`|`OTHERTRADINGACTIVITIES— CharitableGroup`||||
|---|---|---|---|---|
|||`2023`||`2022`|
|||`£`||`£`|
||`Fundraisingevents`|`26,760`||`37,304`|
||`Merchandisesales`|`21,225`||`19,859`|
||`Consultancy`||
`-`|
`6,500`|
|||
`47,985`|
|
`63,663`|
|`5.`|`OTHERINCOME-—CharitableGroup`||||
|||`2023`||`2022`|
||`InvestmentIncome`|`£`||`£`|
||`Depositaccountinterest`|`15,193`||`672`|
||`GovernmentGrants`|`£`||`£`|
||`UKGovernment:Jobretentionschemegrants`|`-`
||`13,439`
|
##
##
##
||`Raisingdonationsandlegacies— `|`CharitableGroup`||||
|---|---|---|---|---|---|
|||||`2023`|`2022`|
|||||`£`|`£`|
||`Wages`|||`164,425`|`124,254`|
||`Eventcosts`|||`7,765`|`6,648`|
||`Travel`|||`3,280`|`1,030`|
||`Onlinegivingadminfees`|||`9,831`|`9,318`|
||`Printing`|||`1,026`|`1,386`|
||`Equipmentunder£1,000`|||`5,568`|`1,642`|
||`Directoverheads— DeprecationFreeholdProperty`|||
`5,957`|
`5,700`|
|||||
`197,852`|
`149,978`|
||`Othertradingactivities`|||||
|||||`2023`|`2022`|
|||||`£`|`£`|
||`Purchasesofgoodsforresale`|||
`16,667`|
`43,224`|
||`Aggregateamounts`|||
`214,349`|
`163,202`|
|`7.`|`CHARITABLEACTIVITIESCOSTS`|`—-CharitableGroup`||||
||`Currentyear`|`Direct`|`Support`|`2023Total`|`2022Total`|
|||`Costs`|`costs`|||
|||`£`|`£`|`£`|`£`|
||`Dogtraining`|`356,774`|`171,857`|`528,631`|`420,812`|
||`Assistancedogplacement`|`600,558`|`288,897`|`889,456`|`810,751`|
||`BioDetectionresearch`|`338,501`|`162,968`|`501,469`|`535,131`|
||`Educationandawareness`|`91,819`|`44,445`|`136,264`|`158,483`|
||`Volunteerliaison`|`152,228`|`72,594`|`224,822`|`195,617`|
||`Total`|
`1,539,880`|
`740,761`|
`2,280,642`|
`2,120,794`|
||`Comparativeyear`|`Direct`|`Support`|`2022Total`||
|||`Costs`|`costs`|||
|||`£`|`£`|`£`||
||`Dogtraining`|`281,584`|`139,228`|`420,812`||
||`Assistancedogplacement`|`§82,924`|`227,826`|`810,751`||
||`BioDetectionresearch`|`395,903`|`139,228`|`535,131`||
||`Educationandawareness`|`101,527`|`56,956`|`158,483`||
||`Volunteerliaison`|`126,004`|`69,614`|`195,617`||
||`Total`|
`1,487,942`
|
`632,852`
|
`2,120,794`
||
##
|`Currentyear`|`Management`|`Finance`|`Governance`|`2023`|`2022`|
|---|---|---|---|---|---|
|||||`Total`|`Total`|
||`£`|`£`|`£`|`£`|`£`|
|`Dogtraining`|`163,620`|`575`|`7,662`|`288,897`|`139,228`|
|`Assistancedogplacement`|`275,050`|`967`|`12,880`|`162,968`|`227,826`|
|`BioDetectionresearch`|`155,157`|`546`|`7,265`|`44,445`|`139,228`|
|`Educationandawareness`|`42,315`|`149`|`1,981`|`72,594`|`56,956`|
|`Volunteerliaison`|`69,115`|`243`|`3,236`|`288,897`|`69,614`|
|`Total`|
`705,258`|
`2,480`|
`33,024`|
`740,761`|
`632,852`|
|`Comparativeyear`|`Management`|`Finance`|`Governance`|`2022`||
|||||`Total`||
||`£`|`£`|`£`|`£`||
|`Dogtraining`|`135,435`|`441`|`3,352`|`139,228`||
|`Assistancedogplacement`|`221,620`|`721`|`5,485`|`227,826`||
|`BioDetectionresearch`|`135,435`|`441`|`3,352`|`139,228`||
|`Educationandawareness`|`55,405`|`180`|`1,371`|`56,956`||
|`Volunteerliaison`|`67,718`|`220`|`1,676`|`69,614`||
|`Total`|
`615,613`
|
`2,003`
|
`15,236`
|
`632,852`
||
##
##
##
|`2023`||||||||
|---|---|---|---|---|---|---|---|
|`Governance`|`Dogtraining`|`Assistance`|`BioDetection`|`Education`||`Volunteer`|`2023`|
|||`dog`|`research`|`and`||`liaison`|`Total`|
|||`placement`||`awareness`||||
||`£`|`£`|`£`|`£`||`£`|`£`|
|`Auditors’remuneration- Audit`|`7,603`|`12,782`|`7,210`|`1,966`||`3,212`|`32,773`|
|`DBSchecks`|`58`|`98`|`55`|`15`||`25`|`251`|
|`Boardmeetingcosts`||||||||
|`Total`|
`7,662`|
`12,880`|
`7,265`|
`1,981`|
|
`3,236`|
`33,024`|
|`2022`||||||||
|`Governance`|`Dogtraining`|`Assistance`|
`BioDetection`|`Education`|`and`|`Volunteer`|`2022`|
|||`dog`|
`research`|`awareness`||`liaison`|`Total`|
|||`placement`||||||
||`£`|`£`|`£`||`£`|`£`|`£`|
|`Auditors’remuneration- Audit`|`3,306`|`5,411`|`3,307`|`1,353`||`1,653`|`15,030`|
|`DBSchecks`|`38`|`62`|
`37`||`15`|`19`|`171`|
|`Boardmeetingcosts`|`8`|`12`|
`8`||`3`|`4`|`35`|
|`Total`|
`3,352`
|
`§,485`
|
`3,352`
|
`1,371`
||
`1,676`
|
`15,236`
|
##
##
||`2023`|`2022`|
|---|---|---|
||`£`|`£`|
|`Auditors'remuneration`|`25,663`|`15,030`|
|`AdditionalAuditfeeinrespectof2022`|`7,110`|`-`|
|`Depreciation- ownedassets`|`122,700`|`109,657`|
|`Operatingleasecharges`|
`13,946`|
`7,736`|
|`Deprecationwasdirectlyallocatedtoactivitiesasfollows:`|||
||`2023`|`2022`|
||`£`|`£`|
|`Raisingdonationsandlegacies`|`5,753`|`5,700`|
|`Dogtraining`|`15,375`|`15,269`|
|`Assistancedogplacementandaftercare`|`15,375`|`15,268`|
|`Educationandawareness`|`1,918`|`1,900`|
|`Volunteerliaison`|`1,918`|`1,900`|
|`Management`|`82,361`|`69,620`|
||
`122,700`
|
`109,657`
|
##
##
##
##
||`2022`|`2021`|
|---|---|---|
||`£`|`£`|
|`Wagesandsalaries`|`1,419,454`|`1,334,447`|
|`Socialsecurity costs`|`131,184`|`110,646`|
|`Pensioncosts`|
`63,162`|
`48,187`|
||
`1,613,801`
|
`1,493,280`
|
||`2023`|`2022`|
|---|---|---|
|`Raisingfunds`|`5`|`4`|
|`Dogtraining,veterinaryandwelfare`|`9`|`9`|
|`Assistancedogplacementandaftercare`|`11`|`13`|
|`BioDetectionresearchprojects`|`11`|`11`|
|`Educationandawareness`|`2`|`2`|
|`Volunteerliaison`|`4`|`4`|
|`Executive`|`3`|`4`|
|`Facilities`|`2`|`2`|
|`Finance`|`4`|`4`|
|`InformationTechnology`|`1`|`-`|
|`Humanresources`|`2`|`2`|
||`54`|`55`|
||||`2023`|`2022`|
|---|---|---|---|---|
|`£80,001`|`-`|`£90,000`|`1`|`1`|
|`£60,000`|`-`|`£70,000`|`0`|`1`|
##
||`Tangible`||`FixedAssets`||||
|---|---|---|---|---|---|---|
||`Freehold`||`Fixtures`|`Motor`||`Total`|
||`property`||`and`|`vehicles`|||
||||`fittings`||||
|`COST`|||||||
|`At1%April2022`|`1,900,107`||
`357,270`|`73,233`||`2,330,610`|
|`Additions`|`17,640`||
`36,992`||`-`|`54,631`|
|`Disposals`||`-`|
`-`|`(5,490)`||`(5,490)`|
|`At31%March2023`|
`1,917,747`|
|
`394262`|
`67,743`|
|
`2,379,752`|
|`DEPRECIATION`|||||||
|`At1°April2022`|`211,718`||
`248,422`|`62,559`||`522,699`|
|`Chargefortheyear`|`38,355`||
`76,608`|`7,737`||`122,700`|
|`Disposals`||`-`|
`-`|`(3,660)`||`(3,660)`|
|`At315!March2023`|
`250,073`|
|
`325,030`|
`66,636`|
|
`641,739`|
|`NETBOOKVALUE`|||||||
|`At31°March2023`|
`1,667,674`|
|
`69,232`|
`1,107`|
|
`1,738,013`|
|`At31%March2022`|`1,688,389`
|
|
`108,848`
|`10,674`
|
|`1,807,911`
|
##
##
|
`Name`|
`Company`|
`Natureof`|
`Classof`|
`|% held`|
`Resultforthe`|
|
`Capitaland`|
|---|---|---|---|---|---|---|---|
||`registration`|`business`|`shares`|`directly`|`year`||`reserves`|
||`number[4]`|||||||
||`(Englandand`|||||||
||`Wales)`|||||||
|
`MDD`|
`08709010`|
`Dormant`|
`Ordinary`|
`|100%`||
`-`|
`£1`|
|`Enterprises`|||||||`(2022:£1)`|
|`Limited[2]`||||||||
|
`Millfield`|
`06312801`
|
`Property`|
`Ordinary`|
`|75%`
|
`Yearended31`|
|
`Yearended31`|
|
`Greenway`||
`management`|||
`July2023:ENil`||
`|July2023:£136`|
|
`BusinessPark`|||||
`(2022:ENil)`||
`(2022:£136)`|
|
`Management`|||||||
|
|
`Limited[2]`|||||||
|
|
`Canine`|
`12646135`
|
`BioDetection`|
`|Ordinary`|
`|100%`
|
`ENil`|
|
`£1`|
|
`Diagnostic`||
`Disease`|||
`(2022:Dormant)`||
`(2022:£1)`|
|
`Innovations`||
`Research`|||||
|
|
`Limited[3]`||
`services`|
|
|
||
|
##
##
|`14.`
`STOCKS— CharityandGroup`|||
|---|---|---|
||`2023`|`2022`|
||`£`|`£`|
|`Stocks`|`5,992`|
`10,648`|
|`15.`
`DEBTORS- Group`|||
||`2023`|`2022`|
||`£`|`£`|
|`Amountsfallingduewithinoneyear:`|||
|`Legacydebtors`|`283,519`|`392,500`|
|`Prepaymentsandaccruedincome`|`24,410`|`232,670`|
|`Otherdebtors`|
`88,696`|
`123,485`|
||
`396,625`|
`748,655`|
|`DEBTORS- Charity`|`2023`|`2022`|
||`£`|`£`|
|`Amountsfallingduewithinoneyear:`|||
|`Legacydebtors`|`283,519`|`392,500`|
|`Prepaymentsandaccruedincome`|`24,410`|`232,670`|
|`Otherdebtors`|`88,696`|`123,485`|
|`NetIntercompanyAccounts— CDILtd`|`-`
||
||`396,625`
|`748,655`
|
##
||`2023`|`2022`|
|---|---|---|
||`£`|`£`|
|`Tradecreditors`|`64,628`|`172,520`|
|`Socialsecurityandothertaxes`|`31,452`|`28,837`|
|`Accrualsanddeferredincome`|`65,457`|`44,776`|
|`Currentaccountswithdormantsubsidiaries`|`4`|`5`|
||
`161,541`|
`246,138`|
|`CREDITORS:AMOUNTSFALLINGDUEWITHINONEYEAR- CharityOnly`|||
||`2023`|`2022`|
||`£`|`£`|
|`Tradecreditors`|`64,628`|`172,520`|
|`Socialsecurityandothertaxes`|`31,452`|`28,837`|
|`Accrualsanddeferredincome`|`65,457`|`44,776`|
|`Currentaccountswithsubsidiaries`|`5`|`5`|
||
`161,541`|
`246,138`|
|`LEASINGAGREEMENTS`|||
|`Minimumleasepaymentsundernon-cancellableoperatingleasesfalldueasfollows:`|||
||`2023`|`2022`|
||`£`|`£`|
|`Withinoneyear`|`14,096`|`12,833`|
|`Betweenoneandfiveyears`|`21,867`|`7,402`|
||
`35,963`
|
`20,235`
|
##
##
##
|`Currentyear`|`At1/4/22`|`Income`|`Expenditure`|`Transfers`|`At31/3/23`|
|---|---|---|---|---|---|
|||||`between`||
|||||`funds`||
||`£`|`£`|`£`|`£`|`£`|
|`Unrestrictedfunds`||||||
|`Generalfund`|`4,218,207`|`1,200,543`|`(1,796,088)`|`-`|`3,622,663`|
|`Restrictedfunds`||||||
|`Cancerstudies`|`8,308`|`-`|`-`|`-`|`8,308`|
|`Namea puppy`|`3,070`|`-`|`(3,070)`||`-`|
|`Medicalalertassistance`|`467,731`|`62,350`|`(168,740)`|`-`|`346,341`|
|`dogs`||||||
|`BioDetection(COVID-19)`|`-`|`25,000`|`(25,000)`|`-`|`-`|
|`Equipment`|`5,637`|`2,441`|`(2,093)`||`5,984`|
|`Regionaldevelopment`|`125,000`|`500,000`|`(500,000)`||`125,000`|
|`BioDetectionDog`|`-`|`88,700`|`-`|`-`|`88,700`|
|`sponsorship`||||||
|`Government`|`-`|`10,000`|`-`|`-`|`10,000`|
|`ApprenticeshipLevy`||||||
|`Scheme`||||||
||
`594,746`|
`688,492`|
`(698,903)`|
`-`|
`584,333`|
|
`TOTALFUNDS`|
`4,812,953`|
`1,889,035`|
`(2,494,991)`|
`-`|
`4,206,996`|
|`Comparativeyear`|`At1/4/21`|`Income`|`Expenditure`|`Transfers`|`At31/3/22`|
|||||`between`||
|||||`funds`||
||`£`|`£`|`£`|`£`|`£`|
|`Unrestrictedfunds`||||||
|`Generalfund`|`4,052,280`|`1,435,585`|`(1,293,373)`|`23,715`|`4,218,207`|
|`Restrictedfunds`||||||
|`Cancerstudies`|`8,308`|`-`|`-`|`-`|`8,308`|
|`Namea puppy`|`3,070`|`-`|`-`|`-`|`3,070`|
|`Medicalalertassistance`|`184,531`|`373,550`|`(105,350)`|`-`|`452,731`|
|`dogs`||||||
|`BioDetection(COVID-19}`|`47,092`|`232,251`|`(279,343)`|`-`|`-`|
|`Equipment`|`10,472`|`5,080`|`-`|`(9,915)`|`5,637`|
|`BioLabrefurbishment`|`14,140`|`150`|`(490)`|`(13,800)`|`-`|
|`Regionaldevelopment`|`225,001`|`475,000`|`(575,001)`|`-`|`125,000`|
|`BioDetectionDog`|`-`|`30,439`|`(30,439)`|`-`|`-`|
|`sponsorship`||||||
||
`492,614`|
`1,116,470`|
`(990,623)`|
`(23,715)`|
`594,746`|
|`TOTALFUNDS`
|
`4,544,894`
|
`2,552,055`
|
`(2,283,996)`
|
`:`
|
`4,812,953`
|
##
##
##
##
##
##
##
##
|
`CanineDiagnisoticInnovationsLtd- SummaryProfitandLossAccount`|
`CanineDiagnisoticInnovationsLtd- SummaryProfitandLossAccount`|
|
|---|---|---|
|`Fortheperiodended31March2023`|||
||
`2023`|
`‘9Monthsto31`|
|||`March2022`|
||`£`|`£`|
|
`Turnover`|
`338,501`|
`0`|
|
`CostofSales`|
`(338,501)`|
`0`|
|
`GrossProfit/ (Loss)`|
`0`|
`0`|
|
`Tax`|
`0`|
`0`|
|
`Profit(orloss)forthefinancialyear`
|
`0`
|
`0`
|
|
`CanineDiagnisoticInnovationsLtd- SummaryBalanceSheet`
||
|
|`Fortheperiodended31March2023`
|||
|
|
`2023`
|
`9Monthsto31`
|
|
||
`March2022`|
|
|
`£`|
`£`|
|
`Calledupsharecapitalnotpaid`|
`1`|
`4`|
|
`Prepaymentsandaccruedincome`|
`0`|
`0`|
|
`Totalassetslesscurrentliablities`|
`0`|
`1`|
|
`Creditors:amountsfallingdueaftermore`|
`0`|
`0`|
|
`thanoneyear`|||
|
`TotalNetAssets`|
`0`|
`0`|
|
`Calledupsharecapital`
|
`1`
|
`1`
|
##
##